LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Nash, Peter [4 ]
Burmester, Gerd R. [1 ]
Cohen, Stanley B. [2 ]
Winthrop, Kevin [3 ]
Rubbert-Roth, Andrea [5 ]
Deodhar, Atul [3 ]
Elkayam, Ori [6 ]
Mysler, Eduardo [7 ]
Tanaka, Yoshiya [8 ]
Liu, Jianzhong [9 ]
Lacerda, Ana P. [9 ]
Pierre-Louis, Bosny J. [9 ]
Shaw, Tim [10 ]
Mease, Philip J. [11 ,12 ]
机构：
[1] Charite, Berlin, Germany
[2] Metroplex Clin Res Ctr, Dallas, TX USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Griffith Univ, Sch Med, Brisbane, Qld, Australia
[5] Cantonal Clin St Gallen, Div Rheumatol, St Gallen, Switzerland
[6] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[7] Org Med Invest, Rheumatol, Buenos Aires, DF, Argentina
[8] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[9] AbbVie Inc, N Chicago, IL USA
[10] AbbVie Ltd, Maidenhead, Berks, England
[11] Swedish Med Ctr, Seattle, WA USA
[12] Providence St Joseph Hlth, Seattle, WA USA
来源：
INTERNAL MEDICINE JOURNAL | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P46
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Shaw, Tim
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana Paula
    Pierre-Louis, Bosny J.
    Mease, Philip J.
    RHEUMATOLOGY, 2022, 61
  • [2] Long-Term Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Burmester, Gerd
    Cohen, Stanley
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana Paula
    Pierre-Louis, Bosny
    Shaw, Tim
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3525 - 3527
  • [3] Long-Term Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Nash, Peter
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana P.
    Pierre-Louis, Bosny J.
    Shaw, Tim
    Mease, Philip J.
    SWISS MEDICAL WEEKLY, 2022, 152 : 16S - 16S
  • [4] LONG-TERM SAFETY OF UPADACITINIB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, AND NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS UP TO 5 YEARS
    Burmester, G. R.
    Stigler, J.
    Rubbert-Roth, A.
    Tanaka, Y.
    Azevedo, V. F.
    Coombs, D.
    Mccaskill, R.
    Lippe, R.
    Wung, P.
    Gensler, L. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 607 - 608
  • [5] MALIGNANCY IN THE UPADACITINIB CLINICAL TRIAL PROGRAMS FOR RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Nash, Peter
    Curtis, Jeffrey
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 44 - 44
  • [6] Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 562 - 564
  • [7] Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
    Poddubnyy, Denis
    Rudwaleit, Martin
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 655 - 673
  • [8] Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin L.
    Nash, Peter
    Irvine, Alan D.
    Deodhar, Atul
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, John
    Lacerda, Ana P.
    Palac, Hannah
    Shaw, Tim
    Mease, Philip J.
    Guttman-Yassky, Emma
    RMD OPEN, 2023, 9 (01):
  • [9] Risk: Benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis
    Fleischmann, Roy
    Iqbal, Imran
    DRUGS & AGING, 2007, 24 (03) : 239 - 254
  • [10] Risk: Benefit Profile of Etanercept in Elderly Patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis
    Roy Fleischmann
    Imran Iqbal
    Drugs & Aging, 2007, 24 : 239 - 254
12345